Pharma Journalist 8769 posts 0 comments

Propanc Biopharma provided an update on the development of the GMP-compliant investigational medicinal product (IMP) manufacture of PRP for First-In-Human studies. PRP is a solution for…
Read More...

AMRI announced it received a 5-year federal contract award from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), for…
Read More...

Imprimis Pharmaceuticals, an ophthalmology-focused pharmaceutical company, and SightLife Surgical, a cornea-focused organization providing comprehensive services to ophthalmic surgeons,…
Read More...

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that based on positive preclinical data, the…
Read More...

Stealth BioTherapeutics Inc. (Stealth), a clinical-stage biopharmaceutical company developing therapeutics to treat mitochondrial dysfunction, today announced the initiation of…
Read More...

Bayer announced the appointment of Bhavesh Ashar as senior vice president and head of Oncology for the company's Pharmaceuticals Division in the United States. Ashar will report to…
Read More...

Medicortex Finland Oy, a biotechnology company developing a diagnostic kit for brain injury detection based on a medical breakthrough biomarker, recently completed analyzing the results…
Read More...

Concert Pharmaceuticals announced the initiation of a Phase 2a clinical trial evaluating CTP-543 for the treatment of moderate-to-severe alopecia areata, an autoimmune disorder in which…
Read More...

NightstaRx Ltd, a biopharmaceutical company specializing in developing gene therapies for inherited retinal dystrophies, announced the appointment of Scott M. Whitcup, M.D. to its board…
Read More...

Be The Match BioTherapies, an organization offering solutions for delivering autologous and allogeneic cellular therapies, today announced that it has entered into a strategic…
Read More...